My local group is refuting a CCG document. Most of it is finished, but one section says: “Funding of unlicensed medicines e.g. Armour Thyroid for the treatment of hypothyroidism is not supported.”
So far our draft says: "This incorrectly states that Armour (Natural Desiccated Thyroid “NDT”) is unlicensed. NDT is a grandfathered product, which never lost the grandfather status, and is therefore exempt from licensing law because it pre-dates - and has proven effective use - prior to licensing in 1938. NDT was used very effectively by clinicians from the early 1890s through to mid-1970 as the preferred form of therapy for hypothyroidism."
However, someone in the group has commented:
"I have never found proof of this in the UK, it appears to only apply to America.... (the FDA were formed in 1938) In the UK the MHRA was formed in 2003, before this it was called the MCA. If a medicine is used in America, we do not automatically allow its use here. The first comprehensive licensing system for medicines in the UK was the 1968 Medicines Act"
Does anyone know any concrete evidence saying how NDT came into UK, and if it does have to be licensed? What is the status of NDT in UK now?